Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany iito 600x60px
Document › Details

iVention B.V.. (7/31/18). "Press Release: National Institute for Public Health and the Environment (in Dutch RIVM) Selected iVention to Deliver iLES LIMS for the Neonatal Bloodspot Prick Screening (NHS)". Zwolle.

Region Region Netherlands
Organisations Organisation iVention B.V.
  Organisation 2 National Institute for Public Health and the Environment (RIVM) (NL)
  Group Netherlands (govt)
Products Product iLES lab informatics platform
  Product 2 blood screening service
Index term Index term Netherlands (govt)–iVention: LIMS, 201807– supply iLES platform to RIVM for Neonatal Bloodspot Prick Screening
Person Person Kox, Oscar (iVention BV 201807 CEO)
     


iVention is proud to announce that RIVM via a European Tender has chosen iLES as their new LIMS for NHS to replace the current LIMS system.

“The assignment is an essential milestone in our ambition to increase our presence in the Healthcare industry. The winning bid proves that our innovative approach provides great benefits to organizations like RIVM in their search for a more flexible, configurable and future-proof NHS LIMS. As our system is based on the latest technologies it offers unrestricted scalability and brings down the total cost of ownership”, says Oscar Kox, CEO of iVention.

The Neonatal heel prick screening is a nationwide screening program for babies in the first week after birth. Annually approximately 170.000 newborns in the Netherlands receive the heel prick. The heel prick screening is the longest running nationwide screening program in public healthcare in the Netherlands.

The analysis of the heel prick blood provides important information about currently 19 rare, often hereditary, serious diseases. Early detection of these diseases is crucial to limit or prevent serious damage to health by timely treatment of babies that are born mostly symptomless. The blood tests are performed by five screening laboratories, of which the laboratory of the RIVM acts as a reference laboratory. The screening laboratories are responsible for the analysis of the heel prick blood and adequate reporting of the results. High demands are placed on the reliability and quality of the blood tests. The analyses must be carried out in a timely manner and with great care.

In July 2015, the Minister of VWS took up the recommendation of the Health Council to add 14 disorders to the screening program. With the expansion plans of the heel prick program to 31 diseases the number of functionalities and complexity will increase significantly. As the current LIMS system is not sufficiently equipped for these changes replacement is necessary. Therefore RIVM published a European Public tender for the delivery, implementation and maintenance of a LIMS for neonatal heel prick screening.

The European tender for this NHS project started early 2017 and finally 4 vendors were selected for a final proposal and a dedicated demonstration to show their fit to the RIVM requirements. Critical elements in the delivery of the new NHS-LIMS include integration with lab equipment, interpretation functionality (decision rules), and the administrative process support system. The full digitalization of the information on the heel prick card with a mobile App has been determined as a potential added value for the near future. Finally iVention was selected as the best qualified partner for the assignment. The agreement was signed on July 5th at RIVM in Bilthoven.

“Great teamwork, passion, talent and challenging work in iVention formed the basis for this new success” according to Oscar Kox, the CEO of iVention.


[Picture] CEO iVention Oscar Kox, MBA (in the middle) signs NHS LIMS Agreement in presence of R.M. (Rob) Riesmeijer, MSc MScPH, Head of the Department of Vaccine Supply and Prevention Programmes (left) and Drs. Jaap van Delden, MBA, Head of the Centre for Population Screening at the RIVM.


About RIVM:

How can we keep ourselves and our environment healthy? That is the challenge facing government authorities at all levels, from the local to the international. The Dutch National Institute for Public Health and the Environment (RIVM) conducts research and provides advice to assist them in this task.

RIVM works to prevent and control outbreaks of infectious diseases. We promote public health and consumer safety, and we help to protect the quality of the environment. RIVM collects and collates knowledge and information from various sources, both national and international. We apply this knowledge ourselves, and we place it at the disposal of policy-makers, researchers, regulatory authorities and the general public. Each year, RIVM produces numerous reports on all aspects of public health, nutrition and diet, health care, disaster management, nature and the environment. RIVM has a total of approximately 1,500 staff and their headquarters is in Bilthoven (NL).


About iVention:

iVention provides laboratories in a wide range of industries with a modern Lab Execution System that combines LIMS, ELN and SDMS features in a single Informatics Platform. The powerful iLES Platform is fully web based, highly flexible and scalable and can be easily deployed from the Cloud and used on any mobile device. iVention is ISO 27001 certified and all our applications are compliant with Good Laboratory Practice (GLP) as well as 21 CFR part 11 guidelines.

   
Record changed: 2018-08-11

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany iito 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px




» top